MARRONE BIO INNOVATIONS INC. Accounts Receivable
MARRONE BIO INNOVATIONS INC. had Accounts Receivable of $12.11 million as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2022-05-13
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $12.11M.
- 2021-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $13.21M.
- 2021-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $12.99M.
- 2021-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $14.50M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2022-03-31 | $12.11M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $13.21M 10-Q · filed 2022-05-13 | |
| 2021-09-30 | $12.99M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $14.50M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $13.53M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $10.11M 10-K/A · filed 2022-05-09 | |
| 2020-03-31 | $10.42M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.92M 10-Q · filed 2020-05-11 | |
| 2019-09-30 | $7.35M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | $7.40M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $8.76M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $2.72M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $3.07M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $4.72M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $4.35M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $3.79M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $1.87M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $5.79M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $8.07M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $3.59M 10-K · filed 2018-04-05 | |
| 2016-09-30 | $2.06M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $4.54M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $4.69M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $2.35M 10-K · filed 2017-04-03 | |
| 2015-09-30 | $1.39M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $2.95M 10-Q · filed 2015-11-10 | |
| 2015-03-31 | $2.17M 10-Q · filed 2015-11-10 | |
| 2014-12-31 | $1.79M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $2.63M 10-K · filed 2015-11-10 | |
| 2014-06-30 | $4.00M 10-K · filed 2015-11-10 | $4.11M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $5.24M 10-K · filed 2015-11-10 | $7.23M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $3.78M 10-K · filed 2015-11-10 | $6.21M 10-K · filed 2014-03-25 |
| 2013-09-30 | $1.41M 10-K · filed 2015-11-10 | $2.05M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $3.40M 10-K · filed 2015-11-10 | $3.90M 10-Q · filed 2013-09-13 |
| 2013-03-31 | $2.48M 10-K · filed 2015-11-10 | |
| 2012-12-31 | $2.83M 10-K · filed 2014-03-25 | $2.97M 10-Q · filed 2013-09-13 |